HuGE Literature Finder
Records
1
-
5
| Gender influences the class III and V ß-tubulin ability to predict poor outcome in colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 May 18 (10): 2964-75. Mariani Marisa, Zannoni Gian Franco, Sioletic Stefano, Sieber Steven, Martino Candice, Martinelli Enrica, Coco Claudio, Scambia Giovanni, Shahabi Shohreh, Ferlini Cristia |
| Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes. Endocrine-related cancer 2011 Jun 18 (3): 371-84. Rudolph Anja, Sainz Juan, Hein Rebecca, Hoffmeister Michael, Frank Bernd, Försti Asta, Brenner Hermann, Hemminki Kari, Chang-Claude Jen |
| Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk. Endocrine-related cancer 2011 Apr 18 (2): 265-76. Sainz J, Rudolph A, Hein R, Hoffmeister M, Buch S, von Schönfels W, Hampe J, Schafmayer C, Völzke H, Frank B, Brenner H, Försti A, Hemminki K, Chang-Claude |
| Estrogen and progesterone-related gene variants and colorectal cancer risk in women. BMC medical genetics 2011 12 (1): 78. Lin Jennifer H, Manson JoAnn E, Kraft Peter, Cochrane Barbara B, Gunter Marc J, Chlebowski Rowan T, Zhang Shumin |
| Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. BMC cancer 2007 7 (1): 123. Bethke Lara, Webb Emily, Sellick Gabrielle, Rudd Matthew, Penegar Stephen, Withey Laura, Qureshi Mobshra, Houlston Richa |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 26, 2022
- Content source: